Anti-DENND5A monoclonal antibody

Pre-made anti-DENND5A monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to DENND5A/DENND5A products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP0681-Ab-1/ GM-Tg-hg-IP0681-Ab-2Anti-Human DENND5A monoclonal antibodyHuman
GM-Tg-rg-IP0681-Ab-1/ GM-Tg-rg-IP0681-Ab-2Anti-Rat DENND5A monoclonal antibodyRat
GM-Tg-mg-IP0681-Ab-1/ GM-Tg-mg-IP0681-Ab-2Anti-Mouse DENND5A monoclonal antibodyMouse
GM-Tg-cynog-IP0681-Ab-1/ GM-Tg-cynog-IP0681-Ab-2Anti-Cynomolgus/ Rhesus macaque DENND5A monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP0681-Ab-1/ GM-Tg-felg-IP0681-Ab-2Anti-Feline DENND5A monoclonal antibodyFeline
GM-Tg-cang-IP0681-Ab-1/ GM-Tg-cang-IP0681-Ab-2Anti-Canine DENND5A monoclonal antibodyCanine
GM-Tg-bovg-IP0681-Ab-1/ GM-Tg-bovg-IP0681-Ab-2Anti-Bovine DENND5A monoclonal antibodyBovine
GM-Tg-equg-IP0681-Ab-1/ GM-Tg-equg-IP0681-Ab-2Anti-Equine DENND5A monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP0681-Ab-1/ GM-Tg-hg-IP0681-Ab-2; GM-Tg-rg-IP0681-Ab-1/ GM-Tg-rg-IP0681-Ab-2;
GM-Tg-mg-IP0681-Ab-1/ GM-Tg-mg-IP0681-Ab-2; GM-Tg-cynog-IP0681-Ab-1/ GM-Tg-cynog-IP0681-Ab-2;
GM-Tg-felg-IP0681-Ab-1/ GM-Tg-felg-IP0681-Ab-2; GM-Tg-cang-IP0681-Ab-1/ GM-Tg-cang-IP0681-Ab-2;
GM-Tg-bovg-IP0681-Ab-1/ GM-Tg-bovg-IP0681-Ab-2; GM-Tg-equg-IP0681-Ab-1/ GM-Tg-equg-IP0681-Ab-2
Products NameAnti-DENND5A monoclonal antibody
Formatmab
Target NameDENND5A
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-DENND5A monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP0681-Ag-1Recombinant multi-species DEN5A/ DENND5A/ EIEE49 protein


    Target information

    Target IDGM-IP0681
    Target NameDENND5A
    Gene ID23258,19347,308942,707945,476844,101085659,784484,100071112
    Gene Symbol and Synonyms1500012B19Rik,DEE49,DENND5A,EIEE49,mKIAA1091,ORF37,RAB6IP1
    Uniprot AccessionQ6IQ26,G3V7Q0
    Uniprot Entry NameDEN5A_HUMAN,DEN5A_RAT
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000184014
    Target ClassificationN/A

    The target: DENND5A, gene name: DENND5A, also named as EIEE49, RAB6IP1. This gene encodes a DENN-domain-containing protein that functions as a RAB-activating guanine nucleotide exchange factor (GEF). This protein catalyzes the conversion of GDP to GTP and thereby converts inactive GDP-bound Rab proteins into their active GTP-bound form. The encoded protein is recruited by RAB6 onto Golgi membranes and is therefore referred to as RAB6-interacting protein 1. This protein binds with RAB39 as well. Alternative splicing results in multiple transcript variants encoding distinct isoforms. Mutations in this gene are associated with early infantile epileptic encephalopathy-49. [provided by RefSeq, Feb 2017].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.